Additionally, CRC cells often resist iron-dependent ferroptosis by continually activating antioxidant defence systems, such as glutathione peroxidase 4 (GPX4) and nuclear factor erythroid 2-related factor 2 (NRF2). This evidence concerns the gene GPX4 and colorectal carcinoma.